세계의 히알루론산 관절내 보충 요법 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore

The global hyaluronic acid (HA) viscosupplementation market was valued at $2.5 billion in 2024 and is projected to grow at a CAGR of 2.9%, reaching $3 billion by 2031.

This market includes four primary product categories:

• Single Injection
• Two Injections
• Three Injections
• Five Injections

Market Insights & Data Coverage

• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Landscape, Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a temporary decline in sales due to postponements of elective procedures.

* By 2022, the market rebounded, returning to steady growth.

• Growing Prevalence of Osteoarthritis:

* Increased aging population and rising osteoarthritis cases are fueling demand for HA viscosupplementation.

• Shift Towards Single-Injection Therapies:

* Convenience and lower patient burden are driving single-injection adoption.

Market Share Insights

Top Competitors in the Global Hyaluronic Acid Viscosupplementation Market (2024):

1 DePuy Synthes

* Market leader with its MONOVISC(R) (single-injection) and ORTHOVISC(R) (three-injection) products.

2 Fidia

* Second-largest market share with its HYMOVIS(R) (two-injection therapy).

3 Sanofi

* Third-largest competitor, offering Synvisc(R) and Synvisc-One(R), benefiting from the growing osteoarthritis market.

Market Segmentation Summary

Hyaluronic Acid Viscosupplementation Market

• Single Injection Market
• Two Injections Market
• Three Injections Market
• Five Injections Market

Global Research Scope

• Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size, Market Shares
• Market Forecasts, Growth Rates
• Units Sold, Average Selling Prices
• Procedure Numbers

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends & Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles & Product Portfolios
• FDA Recalls, Disruptive Technologies
• Disease Overviews

Data Sources:

• Primary Interviews with Industry Leaders
• Government Physician Data & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

• 7.1 Executive Summary
  • 7.1.2 Competitive Analysis
  • 7.1.3 Regions Included
• 7.2 Introduction
  • 7.2.1 Benefits of Viscosupplementation
  • 7.2.2 Synovial Fluid
  • 7.2.3 Product Types
    • 7.2.3.1 Single-Injection Products
    • 7.2.3.2 Two-Injection Cycle Products
    • 7.2.3.3 Three-Injection Cycle Products
    • 7.2.3.4 Three-/Five-Injection Cycle Products
• 7.3 Procedure Numbers
• 7.4 Market Overview
  • 7.4.1 By Segment
  • 7.4.2 By Region
• 7.5 Market Analysis and Forecast
  • 7.5.1 Total Hyaluronic Acid Viscosupplementation Market
  • 7.5.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.5.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
• 7.6 Drivers and Limiters
  • 7.6.1 Market Drivers
  • 7.6.2 Market Limiters
• 7.7 Competitive Market Share Analysis